Literature DB >> 12172046

The effects of antioxidants and nitric oxide modulators on hepatic ischemic-reperfusion injury in rats.

Joong-Eui Rhee1, Sung-Eun Jung, Sang-Do Shin, Gil-Joon Suh, Dong-Young Noh, Yeo-Kyu Youn, Seung-Keun Oh, Kuk-Jin Choe.   

Abstract

Ischemic-reperfusion injury (IRI) is thought to be caused by oxygen radicals. Nitric oxide (NO) also has been thought to play a key role in IRI. This experiment was designed to evaluate the effects of antioxidants and NO supplement on hepatic IRI. Male Sprague-Dawley rats were divided into five groups: a sham operation group, a group with IRI, and three groups with vitamin C combined with vitamin E (VC&VE), L-arginine and N(G)-nitro-L-arginine (NNLA) injected after IRI. IRI was induced by clamping of the porta hepatis for 30 minutes and then by declamping. To prevent mesenteric blood congestion, a porto-systemic shunt had been made four weeks before the portal clamping. Biochemical assays of TNF-alpha level and NO2- level in the blood, malondialdehyde level, catalase activity and NO synthase activity in the liver tissue were performed. The results were as follows: IRI increased the malondialdehyde level and exhausted the catalase activity remarkably. VC&VE lowered the malondialdehyde levels and protected against catalase exhaustion, but had no significant effect on the NO production. L-arginine had a definite antioxidant effect, which was much weaker than that of VC&VE. In conclusion, antioxidants and a supplement of NO protected the liver tissue against IRI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172046      PMCID: PMC3054897          DOI: 10.3346/jkms.2002.17.4.502

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  8 in total

1.  Comparative study on the protective role of vitamin C and L-arginine in experimental renal ischemia reperfusion in adult rats.

Authors:  Abd El-Hamid A Mohamed; Noha N Lasheen
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-10-11

2.  Corrective Effect of Verbascoside on Histomorphological Differences and Oxidative Stress in Colon Mucosa of Rats in Which Colon Ischemia-Reperfusion Injury was Induced.

Authors:  Ayşe Nur Değer; Filiz Özyiğit; Fatma Emel Koçak; Zülfü Bayhan; Sezgin Zeren; Özlem Arık; Hakkı Değer
Journal:  Turk J Gastroenterol       Date:  2021-07       Impact factor: 1.852

3.  Influence of Kupffer cells on hepatic signal transduction as demonstrated by second messengers and nuclear transcription factors.

Authors:  Hong Ding; Jie-An Huang; Jing Tong; Xin Yu; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

4.  CD44 disruption attenuates murine hepatic ischemia/reperfusion injury.

Authors:  Min Sung Kim; Ki Ho Lee; Won Mee Lee; Jin Hyun Jun; Dong Hee Kim
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

5.  Suppression of CFTR-mediated Cl secretion of airway epithelium in vitamin C-deficient mice.

Authors:  Yeryung Kim; Hyemin Kim; Hae-Young Yoo; Jae Seung Kang; Sung Joon Kim; Jin Kyoung Kim; Hyun Sung Cho
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

Review 6.  Effects of iNOS in Hepatic Warm Ischaemia and Reperfusion Models in Mice and Rats: A Systematic Review and Meta-Analysis.

Authors:  Richi Nakatake; Mareike Schulz; Christina Kalvelage; Carina Benstoem; René H Tolba
Journal:  Int J Mol Sci       Date:  2022-10-07       Impact factor: 6.208

7.  Antioxidant-Based Therapy Reduces Early-Stage Intestinal Ischemia-Reperfusion Injury in Rats.

Authors:  Gaizka Gutiérrez-Sánchez; Ignacio García-Alonso; Jorge Gutiérrez Sáenz de Santa María; Ana Alonso-Varona; Borja Herrero de la Parte
Journal:  Antioxidants (Basel)       Date:  2021-05-27

8.  Hepatic ischemic preconditioning provides protection against distant renal ischemia and reperfusion injury in mice.

Authors:  Jung Ah Lee; Jin Woo Choi; Jang Hyeok In; Hong Soo Jung; Yong Shin Kim; Yeon Soo Jeon; Yoo Jin Kang; Dae Woo Kim; Yong Gul Lim; Jae Hee Park; Jin Deok Joo
Journal:  J Korean Med Sci       Date:  2012-04-25       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.